Earli
Pre-clinicalEarli’s mission is to make cancer a benign experience by forcing it to reveal and kill itself.
Founded
2018
Focus
Diagnostics
About
Earli’s mission is to make cancer a benign experience by forcing it to reveal and kill itself.
Funding History
3Total raised: $290M
Series B$190MPerceptive AdvisorsJan 15, 2022
Series A$60MCasdin CapitalJun 15, 2021
Seed$40MKhosla VenturesAug 15, 2020
Company Info
TypePrivate
Founded2018
LocationSouth San Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile